Kavita Mishra, MD, MPH

Title(s)Professor, Radiation Oncology
SchoolSchool of Medicine
Address1600 Divisadero, #H1031
San Francisco CA 94115
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San Francisco, San Francisco, CAResidency2008Radiation Oncology
    Harvard School of Public Health, Boston, MAM.P.H.2003Masters in Public Health
    University of California, San Francisco, San Francisco, CAM.D.2002 Medicine
    Harvard University, Cambridge, MAA.B.1998Biology
    Collapse Awards and Honors
    University of California San Francisco2020  - 2020Faculty Scholar, Osher Center for Integrative Medicine
    Particle Therapy Co-Operative Group2015  - 2015Highest ranked scientific abstract
    University of California San Francisco2008  - 2008RSNA Roentgen Resident/Fellow Research Award
    University of California San Francisco2002  - 2002Class Speaker, UCSF School of Medicine Commencement
    University of California San Francisco1999  - 1999Rainer Scholarship for International Health Research
    Harvard University1998  - 1998Harvard College Scholar, Dean's List
    Harvard University1998  - 1998First Class Marshal, Harvard Class of 1998

    Collapse Overview 
    Collapse Overview
    Dr. Kavita K. Mishra is an internationally renowned expert radiation oncologist focused on the treatment of uveal melanomas with proton beam radiotherapy as well as plaque brachytherapy. She earned her undergraduate degree in Biology at Harvard University, followed by her medical degree at the UCSF School of Medicine. She then completed a masters degree at the Harvard School of Public Health. Dr. Mishra finished her residency in radiation oncology at the UCSF Medical Center and thereafter joined the faculty at UCSF.

    Dr. Mishra specializes in the use of proton beam radiation and plaque brachytherapy to treat malignant and benign conditions of the eye. Dr. Mishra believes in a multidisciplinary approach to ocular oncology care with the aim to provide the most efficacious and individualized therapy for her patients. She is active in the national and international ocular oncology community, is the Co-Chair of PTCOG Ocular (Particle Therapy Co-Operative Group) - the largest collection of proton beam ocular radiation therapy institutions, and has multiple significant research publications and oral presentations globally in her areas of expertise.

    Her current research protocols are focused on the clinical outcomes of uveal melanoma patients, particularly with respect to tumor control, preservation of the eye, and quality of life issues. She hopes to continue using a unified, team-oriented approach to maintain excellent outcomes for patients undergoing modern proton beam, plaque therapy, and external beam radiation techniques for ocular malignancies.

    Collapse Research 
    Collapse Research Activities and Funding
    Millimeter scale particle dosimeter for cancer radiotherapy

    Role: Co-Investigator
    Description: Research and development of millimeter scale dosimeter for particle therapy for utilization in cancer radiotherapy real-time dose delivery analysis.
    Long-Term Investigation of Proton Beam Radiation Therapy, Helium Ion, and Plaque Therapy Techniques for Treatment of Uveal Melanoma and Other Ocular Tumors

    Role: Principal Investigator
    Description: Comprehensive analysis of long term clinical, quality of life, vision, and other outcomes for uveal melanoma and other ocular tumor patients treated with proton beam, helium and plaque therapy.

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Gender Affirmation: Individual writing group members are noted in the Acknowledgment section.The following position statement is meant to iterate our support for gender inclusion of both patients and health care providers. Our goal in writing this document is to be as all-encompassing as possible. Acknowledging the plethora and range of gender-related terminology, we will use "transgender and gender diverse." Urogynecology (Hagerstown). 2022 Nov 01; 28(11):735-737. Ferrando C, Tucker L, Harroche J, Mishra K, Knoepp LR, Grimes CL. PMID: 36288111.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Personalized Mind-Body Medicine in Integrative Oncology: Meeting the Moment with Each Patient. J Integr Complement Med. 2022 06; 28(6):457-462. Mishra KK, Victorson D, Mehta DH, Vago DR. PMID: 35549542; PMCID: PMC9232234.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. A Millimeter-scale Single Charged Particle Dosimeter for Cancer Radiotherapy. IEEE J Solid-State Circuits. 2020 Nov; 55(11):2947-2958. Lee K, Scholey J, Norman EB, Daftari IK, Mishra KK, Faddegon BA, Maharbiz MM, Anwar M. PMID: 33281206; PMCID: PMC7709948.
      View in: PubMed   Mentions:
    4. Oral isotretinoin and topical retinoid use in a series of young patients with ocular melanoma. Am J Ophthalmol Case Rep. 2020 Sep; 19:100787. Mishra KK, Scholey JE, Daftari IK, Afshar A, Tsai T, Park S, Quivey JM, Char DH. PMID: 32760850; PMCID: PMC7390773.
      View in: PubMed   Mentions:
    5. Practice Considerations for Proton Beam Radiation Therapy of Uveal Melanoma During the Coronavirus Disease Pandemic: Particle Therapy Co-Operative Group Ocular Experience. Adv Radiat Oncol. 2020 Jul-Aug; 5(4):682-686. Mishra KK, Afshar A, Thariat J, Shih HA, Scholey JE, Daftari IK, Kacperek A, Pica A, Hrbacek J, Dendale R, Mazal A, Heufelder J, Char DH, Sauerwein WAG, Weber DC, Damato BE. PMID: 32337386; PMCID: PMC7179507.
      View in: PubMed   Mentions: 3  
    6. Phase I/II randomized study of proton beam with anti-VEGF for exudative age-related macular degeneration: long-term results. Eye (Lond). 2020 12; 34(12):2271-2279. Mukkamala LK, Mishra K, Daftari I, Moshiri A, Park SS. PMID: 32055016; PMCID: PMC7784696.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    7. Ultrasonography and transillumination for uveal melanoma localisation in proton beam treatment planning. Eye (Lond). 2019 12; 33(12):1904-1910. Lu JE, Welch RJ, Mishra KK, Daftari IK, Park SS. PMID: 31278380; PMCID: PMC7002621.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury. Int J Radiat Oncol Biol Phys. 2018 05 01; 101(1):152-168. Haas-Kogan D, Indelicato D, Paganetti H, Esiashvili N, Mahajan A, Yock T, Flampouri S, MacDonald S, Fouladi M, Stephen K, Kalapurakal J, Terezakis S, Kooy H, Grosshans D, Makrigiorgos M, Mishra K, Poussaint TY, Cohen K, Fitzgerald T, Gondi V, Liu A, Michalski J, Mirkovic D, Mohan R, Perkins S, Wong K, Vikram B, Buchsbaum J, Kun L. PMID: 29619963; PMCID: PMC5903576.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCellsPHPublic Health
    9. Technical Note: Feasibility study of titanium markers in choroidal melanoma localization for proton beam radiation therapy. Med Phys. 2018 Mar; 45(3):1036-1039. Daftari IK, Quivey JM, Chang JS, Mishra KK. PMID: 29377168.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    10. Prevalence of occult pre-malignant or malignant pathology at the time of uterine morcellation for benign disease. Int J Gynaecol Obstet. 2017 May; 137(2):123-128. Von Bargen EC, Grimes CL, Mishra K, Wang R, Haviland MJ, Hacker MR, Carnevale JA, Estes AJ, Elkadry EA. PMID: 28170091; PMCID: PMC5934613.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    11. Phase I/II Randomized Study of Proton Beam with Anti-Vascular Endothelial Growth Factor for Exudative Age-Related Macular Degeneration: One-Year Results. Ophthalmol Retina. 2017 May - Jun; 1(3):217-226. Osmanovic S, Moisseiev E, Mishra KK, Daftari I, Moshiri A, Morse L, Park SS. PMID: 31047424.
      View in: PubMed   Mentions: 3     Fields:    
    12. Temporal Evolution and Dose-Volume Histogram Predictors of Visual Acuity After Proton Beam Radiation Therapy of Uveal Melanoma. Int J Radiat Oncol Biol Phys. 2017 01 01; 97(1):91-97. Polishchuk AL, Mishra KK, Weinberg V, Daftari IK, Nguyen JM, Cole TB, Quivey JM, Phillips TL, Char DH. PMID: 27838186.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    13. Proton therapy for the management of uveal melanoma and other ocular tumors. Chin Clin Oncol. 2016 Aug; 5(4):50. Mishra KK, Daftari IK. PMID: 27558251.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    14. Point/Counterpoint. Particle therapy is ideal for the treatment of ocular melanomas. Med Phys. 2016 Feb; 43(2):631-4. Mishra KK, Chiu-Tsao ST, Orton CG. PMID: 26843226.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    15. Practice Patterns Analysis of Ocular Proton Therapy Centers: The International OPTIC Survey. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):336-343. Hrbacek J, Mishra KK, Kacperek A, Dendale R, Nauraye C, Auger M, Herault J, Daftari IK, Trofimov AV, Shih HA, Chen YE, Denker A, Heufelder J, Horwacik T, Swakon J, Hoehr C, Duzenli C, Pica A, Goudjil F, Mazal A, Thariat J, Weber DC. PMID: 27084651.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    16. New Clinical and Research Programs in Particle Beam Radiation Therapy: The University of California San Francisco Perspective. Int J Part Ther. 2016; 2(3):471-473. Roach M, Schulte R, Mishra K, Faddegon B, Barani I, Lazar A, Blakely EA. PMID: 27099866; PMCID: PMC4834449.
      View in: PubMed   Mentions: 4  
    17. In Reply to Kamrava and McCannel. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):216-7. Mishra KK, Quivey JM, Daftari IK, Weinberg V, Castro JR, Phillips TL, Char DH. PMID: 26279045.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Long-term Results of the UCSF-LBNL Randomized Trial: Charged Particle With Helium Ion Versus Iodine-125 Plaque Therapy for Choroidal and Ciliary Body Melanoma. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):376-83. Mishra KK, Quivey JM, Daftari IK, Weinberg V, Cole TB, Patel K, Castro JR, Phillips TL, Char DH. PMID: 25841624.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    19. Uveal melanoma gene expression profile test result provided for uveal metastasis. Ophthalmic Surg Lasers Imaging Retina. 2014 Sep-Oct; 45(5):441-2. Seider MI, Stewart PJ, Mishra KK, Damato BE. PMID: 25153656.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters. Int J Radiat Oncol Biol Phys. 2013 Oct 01; 87(2):330-6. Mishra KK, Daftari IK, Weinberg V, Cole T, Quivey JM, Castro JR, Phillips TL, Char DH. PMID: 23886415.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    21. Providers' Perspectives on Provision of Family Planning to HIV-Positive Individuals in HIV Care in Nyanza Province, Kenya. AIDS Res Treat. 2013; 2013:915923. Newmann SJ, Mishra K, Onono M, Bukusi EA, Cohen CR, Gage O, Odeny R, Schwartz KD, Grossman D. PMID: 23738058; PMCID: PMC3659431.
      View in: PubMed   Mentions: 18  
    22. Variables impacting care-seeking for pelvic floor disorders among African American women. Female Pelvic Med Reconstr Surg. 2013 Mar-Apr; 19(2):98-102. Washington BB, Raker CA, Mishra K, Sung VW. PMID: 23442507.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    23. Uveal melanoma: molecular pattern, clinical features, and radiation response. Am J Ophthalmol. 2012 Aug; 154(2):227-232.e2. Chappell MC, Char DH, Cole TB, Harbour JW, Mishra K, Weinberg VK, Phillips TL. PMID: 22541662; PMCID: PMC4966158.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    24. Fundus image fusion in EYEPLAN software: an evaluation of a novel technique for ocular melanoma radiation treatment planning. Med Phys. 2010 Oct; 37(10):5199-207. Daftari IK, Mishra KK, O'Brien JM, Tsai T, Park SS, Sheen M, Phillips TL. PMID: 21089753.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    25. Phase II TPDCV protocol for pediatric low-grade hypothalamic/chiasmatic gliomas: 15-year update. J Neurooncol. 2010 Oct; 100(1):121-7. Mishra KK, Squire S, Lamborn K, Banerjee A, Gupta N, Wara WM, Prados MD, Berger MS, Haas-Kogan DA. PMID: 20221671; PMCID: PMC2951507.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    26. Analgesia/pain management in first trimester surgical abortion. Clin Obstet Gynecol. 2009 Jun; 52(2):160-70. Meckstroth KR, Mishra K. PMID: 19407522.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    27. The role of up-front radiation therapy for incompletely resected pediatric WHO grade II low-grade gliomas. Neuro Oncol. 2006 Apr; 8(2):166-74. Mishra KK, Puri DR, Missett BT, Lamborn KR, Prados MD, Berger MS, Banerjee A, Gupta N, Wara WM, Haas-Kogan DA. PMID: 16495375; PMCID: PMC1871938.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    28. Practice considerations for proton beam radiotherapy of uveal melanoma during the COVID-19 pandemic: PTCOG Ocular experience. Advances in Radiation Oncology. 2020 ePub ahead of print. Mishra KK, Afshar A, Thariat J, Shih H, Scholey JE, Daftari IK, Kacperek A, Pica A, Hrbacek J, Dendale R, Mazal A, Heufelder J, Char DH, Sauerwein W, Weber D, Damato B. View Publication.
    Kavita's Networks
    Concepts (159)
    Derived automatically from this person's publications.
    Co-Authors (20)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department